For help on how to get the results you want, see our search tips.
1236 results
Medicine
European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter
Paediatric investigation plans Remove Paediatric investigation plans filter
Summaries of opinion Remove Summaries of opinion filter
Categories
Human Remove Human filter
Authorisation status
Authorised Remove Authorised filter
-
List item
Human medicine European public assessment report (EPAR): Onivyde pegylated liposomal (previously known as Onivyde) (updated)
irinotecan anhydrous free-base, Pancreatic Neoplasms
Date of authorisation: 14/10/2016,
, Revision: 9, Authorised, Last updated: 28/07/2021
-
List item
Human medicine European public assessment report (EPAR): Combivir (updated)
lamivudine, zidovudine, HIV Infections
Date of authorisation: 18/03/1998, Revision: 33, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): Wakix (updated)
pitolisant, Narcolepsy
Date of authorisation: 31/03/2016,
, , Revision: 11, Authorised, Last updated: 28/07/2021
-
List item
Human medicine European public assessment report (EPAR): Epivir (updated)
lamivudine, HIV Infections
Date of authorisation: 08/08/1996, Revision: 47, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): Respreeza (updated)
Human alpha1-proteinase inhibitor, Genetic Diseases, Inborn, Lung Diseases
Date of authorisation: 20/08/2015,, Revision: 9, Authorised, Last updated: 28/07/2021
-
List item
Human medicine European public assessment report (EPAR): SonoVue (updated)
sulphur hexafluoride, Ultrasonography, Echocardiography
Date of authorisation: 26/03/2001, Revision: 18, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): Orphacol (updated)
cholic acid, Digestive System Diseases, Metabolism, Inborn Errors
Date of authorisation: 12/09/2013,
Date of refusal: 25/05/2012,, , 
, Revision: 10, Authorised, Last updated: 28/07/2021
-
List item
Human medicine European public assessment report (EPAR): Orkambi (updated)
Lumacaftor, ivacaftor, Cystic Fibrosis
Date of authorisation: 18/11/2015,, Revision: 25, Authorised, Last updated: 28/07/2021
-
List item
Human medicine European public assessment report (EPAR): Votrient (updated)
pazopanib, Carcinoma, Renal Cell
Date of authorisation: 14/06/2010, Revision: 27, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): MicardisPlus (updated)
telmisartan, hydrochlorothiazide, Hypertension
Date of authorisation: 19/04/2002, Revision: 30, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): Rekambys (updated)
rilpivirine, HIV Infections
Date of authorisation: 17/12/2020,, Revision: 1, Authorised, Last updated: 28/07/2021
-
List item
Human medicine European public assessment report (EPAR): Herceptin (updated)
trastuzumab, Stomach Neoplasms, Breast Neoplasms
Date of authorisation: 28/08/2000, Revision: 40, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): Trizivir (updated)
abacavir (as sulfate), lamivudine, zidovudine, HIV Infections
Date of authorisation: 27/12/2000, Revision: 38, Authorised, Last updated: 28/07/2021 -
List item
Human medicine European public assessment report (EPAR): Tafinlar (updated)
dabrafenib mesilate, Melanoma
Date of authorisation: 26/08/2013, Revision: 25, Authorised, Last updated: 27/07/2021 -
List item
Human medicine European public assessment report (EPAR): Imfinzi (updated)
durvalumab, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 21/09/2018,, Revision: 8, Authorised, Last updated: 27/07/2021
-
List item
Human medicine European public assessment report (EPAR): Skysona (updated)
elivaldogene autotemcel, Adrenoleukodystrophy
Date of authorisation: 16/07/2021,, , Authorised, Last updated: 27/07/2021
-
List item
Human medicine European public assessment report (EPAR): MabThera (updated)
rituximab, Lymphoma, Non-Hodgkin, Arthritis, Rheumatoid, Leukemia, Lymphocytic, Chronic, B-Cell
Date of authorisation: 02/06/1998, Revision: 54, Authorised, Last updated: 27/07/2021 -
List item
Human medicine European public assessment report (EPAR): Humira (updated)
adalimumab, Spondylitis, Ankylosing, Arthritis, Juvenile Rheumatoid, Uveitis, Colitis, Ulcerative, Psoriasis, Arthritis, Psoriatic, Crohn Disease, Arthritis, Rheumatoid
Date of authorisation: 08/09/2003, Revision: 84, Authorised, Last updated: 27/07/2021 -
List item
Human medicine European public assessment report (EPAR): Lonquex (updated)
lipegfilgrastim, Neutropenia
Date of authorisation: 25/07/2013, Revision: 21, Authorised, Last updated: 27/07/2021 -
List item
Human medicine European public assessment report (EPAR): Brintellix (updated)
Vortioxetine, Depressive Disorder, Major
Date of authorisation: 18/12/2013, Revision: 18, Authorised, Last updated: 27/07/2021 -
List item
Human medicine European public assessment report (EPAR): Verquvo (updated)
Vericiguat, Heart Failure
Date of authorisation: 16/07/2021,, Authorised, Last updated: 27/07/2021
-
List item
Human medicine European public assessment report (EPAR): Lacosamide UCB (updated)
lacosamide, Epilepsies, Partial
Date of authorisation: 26/08/2019, Revision: 2, Authorised, Last updated: 27/07/2021 -
List item
Human medicine European public assessment report (EPAR): Aubagio (updated)
Teriflunomide, Multiple Sclerosis
Date of authorisation: 26/08/2013, Revision: 19, Authorised, Last updated: 26/07/2021 -
List item
Human medicine European public assessment report (EPAR): Fulphila (updated)
pegfilgrastim, Neutropenia
Date of authorisation: 20/11/2018,, 
, Revision: 7, Authorised, Last updated: 26/07/2021
-
List item
Human medicine European public assessment report (EPAR): Kigabeq (updated)
vigabatrin, Spasms, Infantile, Epilepsies, Partial
Date of authorisation: 20/09/2018, Revision: 4, Authorised, Last updated: 26/07/2021